Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 1
Barron's had a short write-up. IIRC $8B market cap (at $34, so more like $7B now), $9.6B in debt. Forward P/E probably around 10, EV/EBITDA 16 so in line with mature drug companies. 80% revenue non-US. May institute a dividend of ~3%. Company expects low to mid single digit growth.
Could be a nice boring stock. Getting dumped now as usually happens after a 10:1 spinoff. I had good luck with KTB so I bought a bit, will buy more if it keeps falling.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.